MedPath

Ayurvedic medicine in Allergic conjunctivitis

Phase 2
Conditions
Health Condition 1: H108- Other conjunctivitis
Registration Number
CTRI/2023/07/055509
Lead Sponsor
Sane Guruji Arogya Kendra
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Patient suffering from Vataja Abhishyanda with symptoms like Netra Toda, Sangharsha, Shishirashruta, and Alpa Shopha.

2) The patient of age from 18 to 60 years.

3) Irrespective of gender.

Exclusion Criteria

1) Patient with Pittaj and Kaphaj Abhishyanda Lakshana.

2) Patients with any other systemic diseases such as, DM, HTN etc.

3) Any other severe ocular infections like corneal ulceration.

4) Acute keratoconjunctivitis, vernal keratoconjunctivitis, Giant papillary conjunctivitis.

5) manifestations such as chalazion, stye.

6) Sub conjunctival hemorrhage, corneal ulcer.

7) Pregnant women, nursing women.

8) All renal dysfunctional diseases.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate efficacy of oral administration of <br/ ><br>Musta Yashtyadi Kwath Ghanavati in Vataj Abhishyanda w.r.t. Simple allergic conjunctivitis. The effect of treatment will be assessed on the presence or absence of eosinophil count in tear before and after treatment. the duration of treatment will be one week with follow up on 4th and 7th day.Timepoint: To evaluate efficacy of oral administration of <br/ ><br>Musta Yashtyadi Kwath Ghanavati in Vataj Abhishyanda w.r.t. Simple allergic conjunctivitis
Secondary Outcome Measures
NameTimeMethod
To compare the efficacy of oral administration of <br/ ><br>Musta Yashtyadi Kwath Ghanavati with Tab. Levocetrizine 5mg in Vataj Abhishyanda w.r.t. Simple allergic conjunctivitis. <br/ ><br> <br/ ><br>The effect of treatment will be assessed on the presence or absence of eosinophil count in tear before & after treatment in both groups & will be compared. The duration of treatment will be one week with follow-up on 4th & 7th day for both the groupsTimepoint: Total duration of study is 18 Months
© Copyright 2025. All Rights Reserved by MedPath